5-(3-Naphthalen-1-yl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione

ID: ALA4164820

PubChem CID: 145959819

Max Phase: Preclinical

Molecular Formula: C17H12N2O2S

Molecular Weight: 308.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(=S)NC(=O)C1=C/C=C/c1cccc2ccccc12

Standard InChI:  InChI=1S/C17H12N2O2S/c20-15-14(16(21)19-17(22)18-15)10-4-8-12-7-3-6-11-5-1-2-9-13(11)12/h1-10H,(H2,18,19,20,21,22)/b8-4+

Standard InChI Key:  GJNFROAPKWKRER-XBXARRHUSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   14.0578   -7.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3500   -7.8429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6423   -7.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6423   -6.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3500   -6.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0578   -6.6163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9304   -7.8429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3500   -5.3896    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7656   -7.8429    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.9304   -6.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2226   -6.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5148   -6.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8029   -6.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8029   -7.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0951   -7.8429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3874   -7.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3874   -6.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6796   -6.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6796   -5.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3874   -4.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0951   -5.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0951   -6.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  3  7  2  0
  5  8  2  0
  1  9  2  0
 10 11  1  0
 11 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 13 22  2  0
 17 22  1  0
 12 13  1  0
  4 10  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4164820

    ---

Associated Targets(Human)

CHL-1 (186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-903 (393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 308.36Molecular Weight (Monoisotopic): 308.0619AlogP: 2.31#Rotatable Bonds: 2
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.44CX Basic pKa: CX LogP: 3.19CX LogD: 2.91
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.51Np Likeness Score: -0.71

References

1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK..  (2018)  Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells.,  143  [PMID:29133035] [10.1016/j.ejmech.2017.11.006]

Source